Sign in
4

Changes in Ownership

Milestone Pharmaceuticals Inc. Filed Acc 0001209191-22-045474

Options or other derivatives

  • Director acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
TOMSICEK MICHAEL JOHN Director 2022-07-05 Grant or award · Stock Option (right to buy) +30,000 30,000 D
Loading xslF345X03/doc4.xml…